The Hawaii Minority/Underserved NCORP

夏威夷少数民族/服务不足的 NCORP

• 批准号: 10224798
• 负责人: Jared Acoba
• 金额: $ 132.83万
• 依托单位: UNIVERSITY OF HAWAII AT MANOA
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10224798
• 关键词: Address; Adolescent and Young Adult; Advocate; Asian Americans; Cancer Burden; Cancer Center; Cancer Control; Caring; Chinese People; Clinical Oncology; Clinical Trials; Communities; Community Clinical Oncology Program; Decision Aid; Disease; Elderly; Enrollment; Ethnic group; Filipino; Goals; Grant; Guam; Guideline Adherence; Hawaii; Health Personnel; Healthcare; Hospitals; Image; Individual; Infrastructure; Institution; Intervention; Japanese Population; Koreans; Leadership; Lesbian Gay Bisexual Transgender; Lesbian Gay Bisexual Transgender Queer; Malignant Neoplasms; Minority; Modality; Native Hawaiian; Oncologist; Pacific Island Americans; Patient-Focused Outcomes; Patients; Physicians' Offices; Population; Populations at Risk; Prevention; Provider; Research; Research Design; Research Infrastructure; Research Personnel; Risk; Rural; Sexual and Gender Minorities; Site; Symptoms; Training; Underrepresented Populations; Underserved Population; Universities; University Hospitals; Work; base; cancer care; cancer clinical trial; cancer prevention; cancer therapy; care delivery; cultural competence; data management; ethnic minority population; experience; financial toxicity; health care delivery; health care disparity; health disparity; improved; low socioeconomic status; multi-ethnic; personalized medicine; racial and ethnic; racial minority; research study; screening; survivorship; underserved minority; working group

The overall goal of the Hawaiʻi Minority/Underserved NCORP is to provide access and facilitate enrollment of Hawaii’s diverse, multiethnic population to NCI sponsored trials. Thus we will enhance accrual of underrepresented populations including Native Hawaiians, other Pacific Islanders, Asian-Americans (Chinese, Japanese, Filipino and Korean), adolescents and young adults (AYA), the elderly and sexual and gender minorities (LGBTQ). Our NCORP is the primary provider of NCI clinical trials and cancer care delivery research (CCDR) in the State of Hawaiʻi where nearly 75% of the population is comprised of multiple minority racial/ethnic groups. The Hawaiʻi M/U NCORP supports an integrated network of affiliates and sub-affiliates with the extensive menu of cancer studies, research infrastructure and data management. Our NCORP has successfully extended CCDR studies from the originally designated sites to other hospital affiliate sites with plans to further extend them to physician office sites. We solicit community input from Native Hawaiian and LGBTQ advocates to review the suitability of trials as well as to address their healthcare needs. Non medical oncology community investigators and staff have leadership responsibility in imaging, prevention and CCDR studies. Our NCORP leaders have extensive experience in cancer clinical trials, health care delivery and disparities. They have served on multiple NCI committees. Participation in NCI’s personalized medicine, cancer control, prevention, treatment and CCDR research will further reduce cancer health care disparities and the cancer burden for the people of Hawaiʻi and beyond.

夏威夷少数民族/服务不足的NCORP的总体目标是提供访问权限和 促进夏威夷多样性的入学，多民族人口向NCI赞助的试验。 我们将提高代表性不足的人群的准确性 夏威夷人，其他太平洋岛民，亚裔美国人（中国，日本，菲律宾和 韩国），青少年和年轻人（AYA），年长的性和性别 少数民族（LGBTQ）。我们的NCORP是NCI临床试验和癌症的主要提供商 夏威夷州的护理递送研究（CCDR）几乎有75％ 由多个少数种族/族裔组成。夏威夷M/U NCORP支持 综合网络的分支机构和子伴约网络，并附有广泛的癌症菜单 研究，研究基础设施和数据管理。我们的NCORP成功 从最初指定的地点到其他医院会员站点的扩展CCDR研究 计划进一步将其扩展到实体办公地点。我们从 夏威夷本地人和LGBTQ倡导者审查试验的适用性以及 满足他们的医疗保健需求。非医学肿瘤社区调查人员和员工 在成像，预防和CCDR研究中承担领导责任。我们的ncorp 领导者在癌症临床试验，医疗保健提供和 差异。他们曾在多个NCI委员会任职。参与NCI 个性化医学，癌症控制，预防，治疗和CCDR研究将 进一步减少癌症医疗保健分布和癌症的癌症 夏威夷及以后。